[{"AccountsPayableCurrent_0_Q3_USD":1784000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":0.0,"OtherSundryLiabilities_0_Q3_USD":495000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-138000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-138000.0,"OtherNoncashIncomeExpense_3_Q3_USD":52000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":0.0,"OtherLiabilitiesCurrent_0_Q3_USD":2874000.0,"OtherCostAndExpenseOperating_3_Q3_USD":0.0,"OtherCostAndExpenseOperating_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-2000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-2000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":0.0,"OtherAssetsNoncurrent_0_Q3_USD":1877000.0,"OtherAssetsMiscellaneous_0_Q3_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1107000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1379000.0,"OperatingIncomeLoss_3_Q3_USD":-59957000.0,"OperatingIncomeLoss_1_Q3_USD":-23381000.0,"NonoperatingIncomeExpense_3_Q3_USD":-1163000.0,"NonoperatingIncomeExpense_1_Q3_USD":-798000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"NetIncomeLoss_3_Q3_USD":-61120000.0,"PreferredStockSharesAuthorized_0_Q3_shares":33333.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":12000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":87574000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":93823000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1361000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q3_USD":0.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":38888000.0,"StockholdersEquity_0_Q3_USD":38888000.0,"ShortTermInvestments_0_Q3_USD":0.0,"ShareBasedCompensation_3_Q3_USD":3281000.0,"ShareBasedCompensation_1_Q3_USD":1400000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":31503000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":13664000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2389127000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":28454000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":9717000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":6329000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":308000.0,"ProfitLoss_3_Q3_USD":-61120000.0,"ProfitLoss_1_Q3_USD":-24179000.0,"ProceedsFromStockPlans_3_Q3_USD":59000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":144000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3769000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":93823000.0,"NetIncomeLoss_1_Q3_USD":-24179000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":12000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-24179000.0,"CommonStockValue_0_Q3_USD":97000.0,"CommonStockSharesOutstanding_0_Q3_shares":96679923.0,"CommonStockSharesIssued_0_Q3_shares":96679923.0,"CommonStockSharesAuthorized_0_Q3_shares":266500000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":54882000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":95276000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":95276000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":354000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":95276000.0,"AssetsCurrent_0_Q3_USD":99045000.0,"Assets_0_Q3_USD":101230000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":77600000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":74300000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q3_USD":131000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":391000.0,"AdditionalPaidInCapital_0_Q3_USD":2427918000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":0.0,"AccruedLiabilitiesCurrent_0_Q3_USD":10444000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-61122000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-54871000.0,"ConversionOfStockAmountConverted1_3_Q3_USD":3370000.0,"CostsAndExpenses_3_Q3_USD":59957000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":97753000.0,"LongTermDebtCurrent_0_Q3_USD":47240000.0,"LiabilitiesCurrent_0_Q3_USD":62342000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":101230000.0,"Liabilities_0_Q3_USD":62342000.0,"InvestmentIncomeNet_3_Q3_USD":28000.0,"InvestmentIncomeNet_1_Q3_USD":9000.0,"InterestPaidNet_3_Q3_USD":158000.0,"InterestExpense_3_Q3_USD":644000.0,"InterestExpense_1_Q3_USD":531000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-856000.0,"IncreaseDecreaseInOperatingLiabilities_3_Q3_USD":1769000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-18000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-7000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.7,"EarningsPerShareDiluted_1_Q3_USD":-0.26,"EarningsPerShareBasic_3_Q3_USD":-0.7,"EarningsPerShareBasic_1_Q3_USD":-0.26,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_3_Q3_USD":0.0,"DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_1_Q3_USD":0.0,"DepreciationAndAmortization_3_Q3_USD":395000.0,"CostsAndExpenses_1_Q3_USD":23381000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":87574000.0,"Ticker":"CTIC","CIK":"891293","name":"CTI BIOPHARMA CORP","OfficialName":"CTI BioPharma Corp. (DE) Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"472610380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]